• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishGo to App
    Quantisnow Logo

    © 2026 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI superconnector for talent & startupsNEWLLM Arena
    Legal
    Terms of usePrivacy policyCookie policy

    83 Biggest Movers From Yesterday

    6/9/22 5:44:29 AM ET
    $ACLX
    $ADTH
    $AERC
    $AMLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care
    Computer Software: Programming Data Processing
    Technology
    Get the next $ACLX alert in real time by email

    Gainers

    • Symbotic Inc. (NASDAQ:SYM) shares surged 120.6% to settle at $20.07 on Wednesday. Symbotic reported the completion of its business combination with SVF Investment Corp. to become a publicly traded company.
    • HeartCore Enterprises, Inc. (NASDAQ:HTCR) shares jumped 114.7% to close at $2.19 on Wednesday after the company authorized a $3.5 million buyback.
    • India Globalization Capital, Inc. (NYSE:IGC) gained 93.5% to close at $0.82. India Globalization Capital was granted U.S. Patent titled 'Method And Composition For Treating Seizure Disorders (Such As Epilepsy).'
    • Qutoutiao Inc. (NASDAQ:QTT) climbed 71.6% to close at $1.63. Shares of several Chinese companies traded higher after Chinese regulators approved some video games for release, which has increased optimism that the country is easing pressure on its tech sector.
    • VivoPower International PLC (NASDAQ:VVPR) gained 40% to settle at $2.24.
    • The Very Good Food Company Inc. (NASDAQ:VGFC) surged 38.8% to close at $0.2915.
    • Kiora Pharmaceuticals, Inc. (NASDAQ:KPRX) surged 31.9% to close at $0.48.
    • Youdao, Inc. (NYSE:DAO) climbed 30% to settle at $6.76.
    • Athersys, Inc. (NASDAQ:ATHX) gained 28.4% to close at $0.3827.
    • Imperial Petroleum Inc. (NASDAQ:IMPP) climbed 27.1% to settle at $0.75 after gaining more than 9% on Tuesday.
    • Annovis Bio, Inc. (NYSE:ANVS) jumped 26.9% to close at $13.70.
    • MINISO Group Holding Limited (NYSE:MNSO) climbed 26.8% to close at $6.90.
    • Fangdd Network Group Ltd. (NASDAQ:DUO) gained 24.8% to close at $3.07.
    • Stealth BioTherapeutics Corp (NASDAQ:MITO) climbed 24.5% to close at $0.33 after the company announced new SBT-272 data demonstrating improvement in upper motor neuron function in ALS disease model at the Keystone Neurodegeneration Symposium.
    • Cidara Therapeutics, Inc. (NASDAQ:CDTX) jumped 24.5% to close at $0.5851.
    • Limoneira Company (NASDAQ:LMNR) gained 22.3% to close at $13.91 after the company reported better-than-expected Q2 EPS results.
    • HUTCHMED (China) Limited (NASDAQ:HCM) rose 22% to settle at $11.39.
    • Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) gained 22% to close at $14.65. The U.S. Food and Drug Administration recently extended the review of New Drug Application (NDA) by three months, submitted by Amylyx Pharmaceuticals for its lead drug candidate AMX0035 with regard to the treatment of patients with amyotrophic lateral sclerosis (ALS).
    • Rekor Systems, Inc. (NASDAQ:REKR) surged 21.9% to settle at $2.62.
    • Titan Pharmaceuticals, Inc. (NASDAQ:TTNP) jumped 21.6% to close at $0.5594.
    • Cyren Ltd. (NASDAQ:CYRN) gained 21.4% to close at $2.16 after the company entered into an agreement with Content Services Group to sell all equity interests in its legacy secure email gateway business.
    • OneConnect Financial Technology Co., Ltd. (NASDAQ:OCFT) rose 21.2% to close at $1.60 after the company board approved to upsize its share repurchase program.
    • Bluejay Diagnostics, Inc. (NASDAQ:BJDX) gained 20.6% to settle at $1.29.
    • Nutex Health, Inc. (NASDAQ:NUTX) rose 20.6% to close at $8.03.
    • ContraFect Corporation (NASDAQ:CFRX) gained 20% to settle at $3.90. WBB Securities upgraded ContraFect from Buy to Strong Buy and announced a $7 price target.
    • Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) jumped 20% to close at $0.2394.
    • Quotient Limited (NASDAQ:QTNT) surged 19.5% to close at $0.4184.
    • Quotient and Theradiag announced partnership To 'advance autoimmune disease diagnostics.'
    • I-Mab (NASDAQ:IMAB) gained 19.4% to close at $10.76. I-Mab announced completion of patient enrollment in Phase III clinical trial of eftansomatropin alfa for treatment of pediatric growth hormone deficiency.
    • Eos Energy Enterprises, Inc. (NASDAQ:EOSE) rose 19.4% to settle at $2.15.
    • Exscientia plc (NASDAQ:EXAI) jumped 19.3% to settle at $15.97.
    • Scienjoy Holding Corporation (NASDAQ:SJ) gained 19.1% to close at $3.00.
    • Dingdong (Cayman) Limited (NASDAQ:DDL) rose 18.9% to settle at $5.54.
    • TG Therapeutics, Inc. (NASDAQ:TGTX) climbed 18.7% to close at $5.01.
    • Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) rose 18.6% to settle at $0.7990.
    • eFFECTOR Therapeutics, Inc. (NASDAQ:EFTR) gained 18.5% to settle at $1.54.
    • Exicure, Inc. (NASDAQ:XCUR) shares gained 18.5% to settle at $0.1339 after declining around 6% on Tuesday.
    • ToughBuilt Industries, Inc. (NASDAQ:TBLT) jumped 18.5% to close at $5.70.
    • Energy Focus, Inc. (NASDAQ:EFOI) shares rose 18.4% to close at $2.70 after jumping more than 46% on Tuesday. The company recently announced a $3.5 million private placement priced at-the-market under Nasdaq rules.
    • Lannett Company, Inc. (NYSE:LCI) gained 18.4% to settle at $0.6901.
    • DBV Technologies S.A. (NASDAQ:DBVT) jumped 18.3% to close at $1.81 after the company reported topline results from its Phase 3 EPITOPE trial and said the trial met the primary endpoint.
    • CTI BioPharma Corp. (NASDAQ:CTIC) climbed 17.6% to close at $6.27.
    • Calithera Biosciences, Inc. (NASDAQ:CALA) gained 17.1% to settle at $0.2342.
    • Rubius Therapeutics, Inc. (NASDAQ:RUBY) gained 17% to close at $1.24.
    • 17 Education & Technology Group Inc. (NASDAQ:YQ) jumped 17% to close at $2.82.
    • Plus Therapeutics, Inc. (NASDAQ:PSTV) gained 16.9% to close at $0.7599.
    • Austin Gold Corp. (NYSE:AUST) surged 16.4% to close at $1.99.
    • Redbox Entertainment Inc. (NASDAQ:RDBX) gained 16.1% to close at $9.93.
    • Pluristem Therapeutics Inc. (NASDAQ:PSTI) jumped 16% to settle at $1.45.
    • Bellicum Pharmaceuticals, Inc. (NASDAQ:BLCM) gained 15.7% to close at $1.18.
    • BeyondSpring Inc. (NASDAQ:BYSI) surged 15.5% to close at $2.16.
    • Gaotu Techedu Inc. (NYSE:GOTU) rose 15% to close at $1.84. Gaotu Techedu recently announced Q1 earnings results.
    • Alibaba Group Holding Limited (NYSE:BABA) jumped 14.7% to settle at $119.62. The rally came on investor hopes the Chinese government will continue to ease pressure on its tech companies increased after its National Press and Publication Administration approved 60 video games for computers and smartphones.
    • SQL Technologies Corp. (NASDAQ:SKYX) gained 14.4% to close at $2.39.
    • Arcellx, Inc. (NASDAQ:ACLX) climbed 12.8% to settle at $19.16.
    • Katapult Holdings, Inc. (NASDAQ:KPLT) gained 12.5% to close at $13.70.
    • Kingsoft Cloud Holdings Limited (NASDAQ:KC) gained 11.9% to close at $5.54 after reporting Q1 results. Kingsoft Cloud reported first-quarter FY22 revenue growth of 19.9% year-on-year to $342.9 million, beating the consensus of $312.2 million.
    • SRAX, Inc. (NASDAQ:SRAX) rose 11.7% to close at $4.02. SRAX recently reported fourth-quarter FY21 Sequire revenue growth of 170% year-on-year to $9.6 million, missing the consensus of $10.2 million.
    • TAL Education Group (NYSE:TAL) rose 9.4% to close at $4.99.
    • MediciNova, Inc. (NASDAQ:MNOV) gained 8.9% to close at $2.56. MediciNova said the Phase 2 trial of MN-166 (ibudilast) in hospitalized COVID-19 patients demonstrated significant improvements compared to placebo for all four clinical endpoints analyzed.
    • Tiziana Life Sciences Ltd (NASDAQ:TLSA) climbed 8.3% to close at $0.7935. Tiziana Life Sciences announced second patient showed clinical improvements in the positron emission tomography imaging analysis, neurologic exam, and timed 25-foot walk test, following three months of treatment in secondary progressive multiple sclerosis trial.
    • Evolve Transition Infrastructure LP (NYSE:SNMP) rose 5.5% to close at $0.56 after the company announced court approval of Mesquite Energy, Inc. settlement agreement.


    Losers

    • Integrated Media Technology Limited (NASDAQ:IMTE) fell 67.5% to close at $3.65 on Wednesday.
    • Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) fell 60.2% to close at $0.7005 after the company announced data from the FORWARD Phase 3 clinical trial did not demonstrate statistical significance in the primary efficacy endpoint.
    • Phoenix Motor Inc. (NASDAQ:PEV) dipped 45.9% to close at $4.06. Phoenix Motor priced its initial public offering of 2.1 million shares at $7.50 per share.
    • Loyalty Ventures Inc. (NASDAQ:LYLT) shares tumbled 45.4% to close at $6.02 on Wednesday after the company said it will reevaluate its 2022 revenue and EBITDA guidance and said its AIR MILES reward program and AIR MILES' sponsor Sobeys were unable to align on extension terms.
    • Accelerate Diagnostics, Inc. (NASDAQ:AXDX) dropped 35.7% to close at $0.74.
    • AeroClean Technologies, Inc. (NASDAQ:AERC) shares fell 23.7% to close at $9.23 after jumping 155% on Tuesday. The FDA recently granted clearance for the company's pūrgo technology, classifying it as a class II medical device.
    • Cosmos Holdings Inc. (NASDAQ:COSM) fell 23.4% to close at $0.8201.
    • Odyssey Marine Exploration, Inc. (NASDAQ:OMEX) declined 21.4% to close at $2.53.
    • Microvast Holdings, Inc. (NASDAQ:MVST) fell 21.1% to close at $3.30.
    • Applied UV, Inc. (NASDAQ:AUVI) shares fell 18.8% to close at $1.77 after jumping 96% on Tuesday.
    • NantHealth, Inc. (NASDAQ:NH) dropped 15.9% to close at $0.53. NantHealth, last month, posted a Q1 loss of $0.11 per share.
    • AdTheorent Holding Company, Inc. (NASDAQ:ADTH) fell 15% to close at $6.00.
    • ZIM Integrated Shipping Services Ltd. (NYSE:ZIM) declined 14.7% to close at $58.46.
    • HashiCorp, Inc. (NASDAQ:HCP) fell 14.5% to close at $32.76.
    • Cadre Holdings, Inc. (NYSE:CDRE) dropped 14.1% to close at $24.01. Cadre Holdings announced launch of public primary and secondary offering of 1.75 million of common stock.
    • Boxed, Inc. (NYSE:BOXD) fell 13.5% to close at $3.09. Boxed announced addition to the Russell 2000 index.
    • Consensus Cloud Solutions, Inc. (NASDAQ:CCSI) declined 12.2% to close at $43.08 after the company reported a secondary offering of 2,000,000 shares held by Ziff Davis.
    • The Scotts Miracle-Gro Company (NYSE:SMG) fell 9.5% to $92.45 after the company cut its FY22 EPS guidance below analyst estimates.
    • The Singing Machine Company, Inc. (NASDAQ:MICS) dropped 9.2% to close at $3.57.
    • Matson, Inc. (NYSE:MATX) fell 8.9% to close at $93.13.
    • Smartsheet Inc. (NYSE:SMAR) shares fell 7% to close at $37.76 after the company issued Q2 adjusted EPS guidance below analyst estimates.
    • The Lovesac Company (NASDAQ:LOVE) fell 6.3% to close at $35.62 after the company reported Q1 financial results.
    Get the next $ACLX alert in real time by email

    Crush Q1 2026 with the Best AI Superconnector

    Stay ahead of the competition with Standout.work - your AI-powered talent-to-startup matching platform.

    AI-Powered Inbox
    Context-aware email replies
    Strategic Decision Support
    Get Started with Standout.work

    Recent Analyst Ratings for
    $ACLX
    $ADTH
    $AERC
    $AMLX

    CompanyDatePrice TargetRatingAnalyst
    Eos Energy Enterprises Inc.
    $EOSE
    2/27/2026$20.00Buy → Neutral
    Guggenheim
    Alibaba Group Holding Limited
    $BABA
    2/18/2026Buy → Hold
    Erste Group
    Arcellx Inc.
    $ACLX
    2/12/2026$82.00Buy → Neutral
    Rothschild & Co Redburn
    Kingsoft Cloud Holdings Limited
    $KC
    2/11/2026$15.60Neutral → Buy
    Goldman
    PLUS THERAPEUTICS Inc.
    $PSTV
    2/3/2026$2.00Buy
    Lake Street
    TAL Education Group
    $TAL
    1/30/2026$18.00Neutral → Outperform
    Macquarie
    Alibaba Group Holding Limited
    $BABA
    1/21/2026$190.00Neutral → Buy
    Arete
    Alibaba Group Holding Limited
    $BABA
    1/8/2026$231.00 → $225.00Buy
    Jefferies
    More analyst ratings

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    View All

    EVP, CFO & CAO Scheiwer Mark J bought $49,504 worth of shares (693 units at $71.44), increasing direct ownership by 5% to 15,370 units (SEC Form 4)

    4 - SCOTTS MIRACLE-GRO CO (0000825542) (Issuer)

    2/25/26 11:29:13 AM ET
    $SMG
    Agricultural Chemicals
    Industrials

    Chief Executive Officer Siokas Grigorios bought $145,000 worth of shares (388,532 units at $0.37), increasing direct ownership by 5% to 8,861,914 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/13/26 10:05:37 AM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Chief Executive Officer Siokas Grigorios bought $120,000 worth of shares (291,262 units at $0.41), increasing direct ownership by 4% to 8,473,382 units (SEC Form 4)

    4 - Cosmos Health Inc. (0001474167) (Issuer)

    2/12/26 2:20:08 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    $ACLX
    $ADTH
    $AERC
    $AMLX
    SEC Filings

    View All

    SEC Form 144 filed by Arcellx Inc.

    144 - Arcellx, Inc. (0001786205) (Subject)

    2/27/26 7:31:42 PM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 8-K filed by Odyssey Marine Exploration Inc.

    8-K - ODYSSEY MARINE EXPLORATION INC (0000798528) (Filer)

    2/27/26 5:29:10 PM ET
    $OMEX
    Marine Transportation
    Consumer Discretionary

    SEC Form 10-K filed by TG Therapeutics Inc.

    10-K - TG THERAPEUTICS, INC. (0001001316) (Filer)

    2/27/26 5:05:11 PM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $ADTH
    $AERC
    $AMLX
    FDA approvals

    Live FDA approvals issued by the Food and Drug Administration and FDA breaking news

    View All

    FDA Approval for BRIUMVI issued to TG THERAPEUTICS, INC

    Submission status for TG THERAPEUTICS, INC's drug BRIUMVI (SUPPL-11) with active ingredient UBLITUXIMAB-XIIY has changed to 'Approval' on 10/30/2024. Application Category: BLA, Application Number: 761238, Application Classification:

    10/31/24 4:38:40 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for LEVOFLOXACIN issued to LANNETT CO INC

    Submission status for LANNETT CO INC's drug LEVOFLOXACIN (SUPPL-11) with active ingredient LEVOFLOXACIN has changed to 'Approval' on 09/20/2024. Application Category: ANDA, Application Number: 205222, Application Classification: Labeling

    9/24/24 4:39:48 AM ET
    $LCI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    FDA Approval for MYCOPHENOLATE MOFETIL issued to LANNETT CO INC

    Submission status for LANNETT CO INC's drug MYCOPHENOLATE MOFETIL (SUPPL-7) with active ingredient MYCOPHENOLATE MOFETIL has changed to 'Approval' on 08/13/2024. Application Category: ANDA, Application Number: 214525, Application Classification: REMS

    8/15/24 4:43:42 AM ET
    $LCI
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Press Releases

    Fastest customizable press release news feed in the world

    View All

    Amylyx Pharmaceuticals to Participate in Upcoming March Investor Conferences

    Amylyx Pharmaceuticals, Inc. (NASDAQ:AMLX) ("Amylyx" or the "Company") today announced that management will participate in the following upcoming investor conferences, which are being conducted in-person: TD Cowen 46th Annual Health Care Conference: Fireside Chat on Tuesday, March 3, 2026, at 11:10 a.m. ET in Boston, Massachusetts Leerink Global Healthcare Conference: Fireside chat on Tuesday, March 10, 2026, at 8:00 a.m. ET in Miami, Florida A live webcast of both presentations can be accessed under "Events and Presentations" in the Investor section of the Company's website, https://investors.amylyx.com/events-presentations, and will be available for replay for 90 days following t

    2/26/26 9:00:00 AM ET
    $AMLX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance

    Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and $594.1 million, respectively Target guidance of approximately $875-900 million in total global revenue for 2026 Conference call to be held today, Thursday, February 26, 2026, at 8:30 AM ET NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) (the Company or TG Therapeutics) today announced its financial results for the fourth quarter and full year ended December 31, 2025, along with recent company developments and 2026 financial guidance. Michael S. Weiss, the Company's Chairman and Chief Executive Off

    2/26/26 7:00:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Eos Energy Enterprises Reports Fourth Quarter and Full Year 2025 Financial Results; Delivers More than 7x Year-Over-Year Revenue Growth and Initiates 2026 Revenue Guidance

    $58.0 million in record quarterly revenue with Q4 exceeding the first three 2025 quarters combined Secured over $240 million with nearly 1.1 GWh of new orders in Q4 from eight customers spanning U.S. and international markets, highlighting diversified market demandSuccessfully executed a $600 million senior convertible notes issuance and registered direct common stock offering, ending the year with a record cash balance of $624.6 millionCurrent liquidity and operational funding plan support ongoing operations and substantial doubt no longer exists about Company's ability to continue as a going concern Launched Indensity™, a next-generation architecture built with Spatial Intelligence that ta

    2/26/26 6:31:00 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    View All

    Eos Energy downgraded by Guggenheim with a new price target

    Guggenheim downgraded Eos Energy from Buy to Neutral and set a new price target of $20.00

    2/27/26 8:28:11 AM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    Alibaba downgraded by Erste Group

    Erste Group downgraded Alibaba from Buy to Hold

    2/18/26 9:41:39 AM ET
    $BABA
    Real Estate

    Arcellx downgraded by Rothschild & Co Redburn with a new price target

    Rothschild & Co Redburn downgraded Arcellx from Buy to Neutral and set a new price target of $82.00

    2/12/26 7:20:24 AM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    View All

    Officer Elghandour Rami converted options into 164,548 shares and sold $10,243,267 worth of shares (89,916 units at $113.92), decreasing direct ownership by 55% to 276,051 units (SEC Form 4)

    4 - Arcellx, Inc. (0001786205) (Issuer)

    2/27/26 7:48:11 PM ET
    $ACLX
    Biotechnology: Biological Products (No Diagnostic Substances)
    Health Care

    SEC Form 4 filed by Chief Financial Officer Sims Andrew John Hugh Macintyre

    4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)

    2/27/26 4:08:43 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    SEC Form 4 filed by Chief Executive Officer Hedrick Marc H

    4 - PLUS THERAPEUTICS, INC. (0001095981) (Issuer)

    2/27/26 4:07:51 PM ET
    $PSTV
    Medical/Dental Instruments
    Health Care

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Leadership Updates

    Live Leadership Updates

    View All

    Cosmos Health Appoints Globally Recognized AI-Driven Drug Discovery and Clinical-Stage Biotech Expert Dr. Dimitrios Iliopoulos to Advisory Board

    CHICAGO, Feb. 24, 2026 (GLOBE NEWSWIRE) -- Cosmos Health Inc. ("Cosmos Health" or the "Company") (NASDAQ:COSM), a diversified, vertically integrated global healthcare group, today announced the appointment of Dr. Dimitrios Iliopoulos to its Advisory Board, where he will support the Company's biotechnology initiatives, with a focus on AI-driven drug discovery and clinical-stage therapeutic development. Dr. Iliopoulos is a world-renowned expert in artificial intelligence, drug discovery, and drug development. He currently serves as Co-Founder and CEO of Athos Therapeutics Inc., an AI software and clinical-stage biotechnology company focused on developing precision therapeutics for autoimmun

    2/24/26 12:30:00 PM ET
    $COSM
    Other Pharmaceuticals
    Health Care

    Cyclerion Therapeutics Announces Progress Toward CYC-126 Phase 2 Proof-of-Concept Study with FDA Feedback and Formation of Clinical Advisory Board

    –Received Positive Pre-Investigational New Drug ("IND") Written Feedback from the U.S. Food and Drug Administration ("FDA")– –Clinical Advisory Board ("CAB") Includes Key Leaders across Neuropsychiatry, Anesthesiology, and Clinical Development– –Remain On Track to Initiate CYC-126's Phase 2 Proof-of-Concept ("POC") Study in Treatment Resistant Depression ("TRD") in the Second Half of 2026– CAMBRIDGE, Mass., Feb. 17, 2026 (GLOBE NEWSWIRE) -- Cyclerion Therapeutics, Inc. (NASDAQ:CYCN) ("Cyclerion" or "Company"), a biopharmaceutical company pioneering neuropsychiatric therapies, today announced it has received positive written regulatory feedback and responses from the FDA on CYC-126

    2/17/26 7:00:00 AM ET
    $CYCN
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Rigel Appoints Michael P. Miller to the Board of Directors

    SOUTH SAN FRANCISCO, Calif., Feb. 3, 2026 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (NASDAQ:RIGL) today announced that it has appointed Michael P. Miller to its Board of Directors. Mr. Miller has more than four decades of experience in commercial and leadership roles in the biotechnology and pharmaceutical industries. "Mike has a strong track record of commercial excellence, and we're delighted to have him join our Board," said Raul Rodriguez, Rigel's president and CEO. "His extensive expertise in commercial execution and leadership will provide valuable insights as we execute on our transformational strategic plan, particularly our objectives of growing our current portfolio of medicines

    2/3/26 8:05:00 AM ET
    $RIGL
    Biotechnology: Pharmaceutical Preparations
    Health Care

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Financials

    Live finance-specific insights

    View All

    TG Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results and Raises BRIUMVI Revenue Guidance

    Fourth quarter and full year 2025 total revenue of $192.6 million and $616.3 million, including BRIUMVI U.S. net revenue of $182.7 million and $594.1 million, respectively Target guidance of approximately $875-900 million in total global revenue for 2026 Conference call to be held today, Thursday, February 26, 2026, at 8:30 AM ET NEW YORK, Feb. 26, 2026 (GLOBE NEWSWIRE) -- TG Therapeutics, Inc. (NASDAQ:TGTX) (the Company or TG Therapeutics) today announced its financial results for the fourth quarter and full year ended December 31, 2025, along with recent company developments and 2026 financial guidance. Michael S. Weiss, the Company's Chairman and Chief Executive Off

    2/26/26 7:00:00 AM ET
    $TGTX
    Biotechnology: Pharmaceutical Preparations
    Health Care

    Record Date for 2026 Annual General Meeting of Shareholders

    SHANGHAI, Feb. 25, 2026 /PRNewswire/ -- Dingdong (Cayman) Limited (the "Company") (NYSE:DDL), a leading fresh grocery e-commerce company in China, announces that the record date for the purpose of determining the eligibility of the holders of the Class A ordinary shares and the Class B ordinary shares of the Company, par value US$ 0.000002 each (the "Ordinary Shares"), to vote and attend the forthcoming 2026 annual general meeting of the Company (the "AGM"), will be as of the close of business on Monday, March 9, 2026, Shanghai time (the "Ordinary Share Record Date"). In order to be eligible to vote and attend the AGM, with respect to Ordinary Shares registered on the Company's principal sha

    2/25/26 11:30:00 PM ET
    $DDL
    Catalog/Specialty Distribution
    Consumer Discretionary

    Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call

    HOUSTON, Feb. 25, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ:NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatient departments in 12 states and primary care-centric, risk-bearing physician networks, today announced that it plans to file its Annual Report on Form 10‑K for the fiscal year ended December 31, 2025, on Thursday, March 5, 2026, after the market close. The Company will also issue a corresponding press release summarizing financial results on the same day. Nutex Health will host its earnings conference call on Friday, March 6, 2026, at 9:30 a.m. CT to discuss the Company's financial performance and

    2/25/26 5:29:00 PM ET
    $NUTX
    Real Estate

    $ACLX
    $ADTH
    $AERC
    $AMLX
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    View All

    Amendment: SEC Form SC 13D/A filed by Eos Energy Enterprises Inc.

    SC 13D/A - Eos Energy Enterprises, Inc. (0001805077) (Subject)

    12/17/24 2:48:02 PM ET
    $EOSE
    Industrial Machinery/Components
    Miscellaneous

    SEC Form SC 13G filed by Fangdd Network Group Ltd.

    SC 13G - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:26:40 PM ET
    $DUO
    Real Estate
    Finance

    Amendment: SEC Form SC 13G/A filed by Fangdd Network Group Ltd.

    SC 13G/A - Fangdd Network Group Ltd. (0001750593) (Subject)

    12/16/24 4:24:27 PM ET
    $DUO
    Real Estate
    Finance